Related Experiment Video
Updated: Aug 30, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can
Janardhan Sampath1, Pandy R Long, Robert L Shepard
1Cancer Research Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.
Abstract:
Our effort to identify novel drug-resistant genes in cyclophosphamide-resistant EMT6 mouse mammary tumors led us to the identification of SPF45. Simultaneously, other groups identified SPF45 as a component of the spliceosome that is involved in alternative splicing. We isolated the human homologue and examined the normal human tissue expression, tumor expression, and the phenotype caused by overexpression of human SPF45. Our analyses revealed that SPF45 is expressed in many, but not all, normal tissues tested with predominant expression in normal ductal epithelial cells of the breast, liver, pancreas, and prostate. Our analyses using tissue microarrays and sausages of tumors indicated that SPF45 is highly expressed in numerous carcinomas including bladder, breast, colon, lung, ovarian, pancreatic, and prostate. Interestingly, this study revealed that overexpression of SPF45 in HeLa, a cervical carcinoma cell line, resulted in drug resistance to doxorubicin and vincristine, two chemotherapeutic drugs commonly used in cancer. To our knowledge, this is the first study showing tumor overexpression of an alternate splicing factor resulting in drug resistance.
Insights
Scientists identified SPF45, a spliceosome component, as a factor in cancer drug resistance. Overexpression of SPF45 in tumors and cell lines correlated with resistance to common chemotherapy drugs.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cyclophosphamide resistance in EMT6 mouse mammary tumors prompted the search for novel drug-resistant genes.
- SPF45 was concurrently identified by other researchers as a spliceosome component involved in alternative splicing.
Purpose of the Study:
- To investigate the role of SPF45 in cancer drug resistance.
- To examine the expression pattern of human SPF45 in normal and cancerous tissues.
- To determine the phenotypic effects of SPF45 overexpression in cancer cells.
Main Methods:
- Identification of SPF45 in drug-resistant mouse tumors.
- Isolation and analysis of the human SPF45 homologue.
- Assessment of SPF45 expression in normal human tissues and various carcinomas using tissue microarrays.
- Overexpression studies of SPF45 in HeLa cervical carcinoma cells.
Main Results:
- SPF45 is expressed in various normal human tissues, notably ductal epithelial cells of the breast, liver, pancreas, and prostate.
- High SPF45 expression was observed in multiple carcinomas, including bladder, breast, colon, lung, ovarian, pancreatic, and prostate cancers.
- Overexpression of SPF45 in HeLa cells conferred resistance to doxorubicin and vincristine chemotherapy.
Conclusions:
- SPF45 is a frequently overexpressed splicing factor in numerous human carcinomas.
- Tumor overexpression of SPF45 is linked to acquired resistance to common chemotherapeutic agents.
- This study presents the first evidence of an alternative splicing factor contributing to tumor drug resistance.
Related Concept Videos
Abnormal Proliferation
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

